The molecule is also being tested in over 100 vaccine clinical trials. Rising QS-21 demand from the pharmaceutical industry ...

SAN DIEGO, February 04, 2025--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), ...

As Chairman of Global Vaccines, Dr. Slaoui was directly involved in GSK's vaccine pipeline ... Mosquirix, to prevent malaria; Rotarix®, to prevent rotavirus gastroenteritis; and Synflorix ...

Expert Rev Vaccines. 2008;7(2):223-240. The EMVI is currently supporting preclinical activities at the Statens Serum Institute in Copenhagen and the Institut Pasteur in Paris for the development ...

Other FP9 and MVA polyprotein constructs including combination vaccines with CS and LSA1 antigens are being developed at the University of Oxford with the European Malaria Vaccine Initiative (EMVI ...

GlaxoSmithKline (GSK ... It’s not that the Gates Foundation is snubbing malaria vaccines — as one of Gavi’s biggest donors, Gates is helping to fund the R21 rollout. But rather than put ...

The WHO has given a green light to widespread use of GlaxoSmithKline's malaria vaccine in Africa, in what could be a major turning point in the fight against the disease. The RTS,S/AS01 vaccine ...

Singapore President Tharman Shanmugaratnam visited the vaccine manufacturing facility of Sapigen Biologix, a subsidiary of Bharat Biotech, on Saturday, in Bhubaneswar. Located at the Odisha ...

A malaria vaccine developed by members of the University ... The efficacy is also much higher than the 39% seen with GSK's Mosquirix (RTS,S/AS01), which was, nevertheless, deemed sufficient ...